ASP Isotopes Inc. announced that on January 12, 2024, Joshua Donfeld, a member of the board of directors of the company, provided notice to the Company of his decision to voluntarily step down from the Board, effective immediately. Effective January 14, 2024, the Board appointed Rob Ryan as director, to fill the vacancy on the Board created by the resignation of Mr. Donfeld, Mr. Ryan will serve as a Class I director whose term will expire at the Company?s 2026 annual meeting of stockholders. The Board also appointed Mr. Ryan to serve as a member of the Audit Committee and the Nominating and Corporate Governance Committee of the Board.

Rob Ryan, age 55, is a private investor with more than 30 years? experience in investment banking, private equity and international financial law. Mr. Ryan was a partner of Balbec Capital LP from January 2019 to July 2023 and a managing director of Balbec Capital LP from January 2013 to January 2019.

Prior to joining Balbec Capital LP, Mr. Ryan was associated with a number of international investment banks. Mr. Ryan started his career as a solicitor at a leading U.K. multinational law firm. Mr. Ryan received a LL.B. degree from the University of Leicester.

The Board of directors believes that Mr. Ryan?s significant board experience and financial expertise contribute to the Board?s understanding and ability to analyze complex issues, particularly as the Company looks to grow its business, and qualify him to serve on the board of directors.